Search

Search Constraints

You searched for: Author/Creator Blom, Dirk J.

Search Results

2. Effects of evolocumab therapy and low LDL‐C levels on vitamin E and steroid hormones in Chinese and global patients with type 2 diabetes. Issue 2 (6th March 2020)

3. Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome. Issue 1 (14th October 2016)

5. Heterozygous Familial Hypercholesterolaemia in Specialist Centres in South Africa, Australia and Brazil: Importance of Early Detection and Lifestyle Advice. (June 2018)

6. Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle advice. (October 2018)

7. Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab. Issue 3 (March 2018)

8. LDL-cholesterol target achievement in patients with heterozygous familial hypercholesterolemia at Groote Schuur Hospital: Minority at target despite large reductions in LDL-C. (October 2018)

9. Long-Term Efficacy and Safety of the Microsomal Triglyceride Transfer Protein Inhibitor Lomitapide in Patients With Homozygous Familial Hypercholesterolemia. Issue 3 (18th July 2017)

10. Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town. Issue 2 (February 2021)